☰

Elias Zambidis - Publications

Affiliations: 
Institute for Cell Engineering Johns Hopkins University School of Medicine, Baltimore, MD, United States 
Tree Info Similar researchers PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Buys W, Zambidis ET. Harnessing bioengineered myeloid progenitors for precision immunotherapies. Npj Regenerative Medicine. 8: 66. PMID 38086850 DOI: 10.1038/s41536-023-00343-x  0.37
2022 Zimmerlin L, Park TS, Bhutto I, Lutty G, Zambidis ET. Generation of Pericytic-Vascular Progenitors from Tankyrase/PARP-Inhibitor-Regulated Naïve (TIRN) Human Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 2416: 133-156. PMID 34870835 DOI: 10.1007/978-1-0716-1908-7_10  0.466
2021 Thomas J, Zimmerlin L, Huo JS, Considine M, Cope L, Zambidis ET. Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential. Npj Regenerative Medicine. 6: 25. PMID 34001907 DOI: 10.1038/s41536-021-00135-1  0.485
2020 Park TS, Zimmerlin L, Evans-Moses R, Thomas J, Huo JS, Kanherkar R, He A, Ruzgar N, Grebe R, Bhutto I, Barbato M, Koldobskiy MA, Lutty G, Zambidis ET. Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina. Nature Communications. 11: 1195. PMID 32139672 DOI: 10.1038/S41467-020-14764-5  0.411
2018 Park TS, Zimmerlin L, Evans-Moses R, Zambidis ET. Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency. Journal of Visualized Experiments : Jove. PMID 29939183 DOI: 10.3791/57921  0.495
2018 Zambidis E, Zimmerlin L, Park TS, Evans R, Huo JS, Kanherkar R. Human Pluripotent Stem Cells with Improved Functionality and Efficient Interspecies Chimera Potential Biology of Blood and Marrow Transplantation. 24: S476-S477. DOI: 10.1016/J.Bbmt.2017.12.571  0.548
2017 Zimmerlin L, Park TS, Zambidis ET. Capturing Human Naïve Pluripotency in the Embryo and in the Dish. Stem Cells and Development. 26: 1141-1161. PMID 28537488 DOI: 10.1089/scd.2017.0055  0.445
2016 Klein OR, Buddenbaum J, Tucker N, Chen AR, Gamper CJ, Loeb D, Zambidis E, Llosa NJ, Huo JS, Robey N, Holuba MJ, Kasamon YL, McCurdy SR, Ambinder R, Bolaños-Meade J, et al. Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27888014 DOI: 10.1016/J.Bbmt.2016.11.016  0.313
2016 Nagaria PK, Robert C, Park TS, Huo JS, Zambidis ET, Rassool FV. High-Fidelity Reprogrammed Human IPSCs Have a High Efficacy of DNA Repair and Resemble hESCs in Their MYC Transcriptional Signature. Stem Cells International. 2016: 3826249. PMID 27688775 DOI: 10.1155/2016/3826249  0.384
2016 Zimmerlin L, Park TS, Huo JS, Verma K, Pather SR, Talbot CC, Agarwal J, Steppan D, Zhang YW, Considine M, Guo H, Zhong X, Gutierrez C, Cope L, Canto-Soler MV, ... ... Zambidis ET, et al. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development (Cambridge, England). PMID 27660325 DOI: 10.1242/Dev.138982  0.371
2016 Salomonis N, Dexheimer PJ, Omberg L, Schroll R, Bush S, Huo J, Schriml L, Ho Sui S, Keddache M, Mayhew C, Shanmukhappa SK, Wells J, Daily K, Hubler S, Wang Y, ... Zambidis E, et al. Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cell from the Progenitor Cell Biology Consortium. Stem Cell Reports. PMID 27293150 DOI: 10.1016/J.Stemcr.2016.05.006  0.513
2016 Klein OR, Chen AR, Gamper C, Loeb D, Zambidis E, Llosa N, Huo J, Dezern AE, Steppan D, Robey N, Jo Holuba M, Cooke KR, Symons HJ. Alternative donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26860634 DOI: 10.1016/J.Bbmt.2016.02.001  0.361
2016 Zhu R, Millrod MA, Zambidis ET, Tung L. Variability of Action Potentials Within and Among Cardiac Cell Clusters Derived from Human Embryonic Stem Cells. Scientific Reports. 6: 18544. PMID 26729331 DOI: 10.1038/Srep18544  0.344
2016 Zambidis E, Zimmerlin L, Park TS, Huo JS, Verma K, Pather S, Talbot C, Agarwal J, Steppan D, Considine M, Guo H, Zhang Y, Cope L, Friedman A, Baylin S. Stable Reversion of Conventional Human Pluripotent Stem Cells to a Mouse ESC-like Naïve Ground State Erases Somatic Donor Epigenetic Memory and Significantly Improves Their Hemato-Vascular Differentiation Potency Biology of Blood and Marrow Transplantation. 22: S426. DOI: 10.1016/J.Bbmt.2015.11.972  0.493
2015 Jacoby E, Chen A, Loeb DM, Gamper CJ, Zambidis E, Llosa NJ, Huo J, Cooke KR, Jones R, Fuchs E, Luznik L, Symons HJ. Single agent post-transplantation cyclophosphamide as GVHD prophylaxis after HLA-matched related BMT for pediatric and young adult patients with hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26343947 DOI: 10.1016/J.Bbmt.2015.08.034  0.315
2015 Bazley FA, Liu CF, Yuan X, Hao H, All AH, De Los Angeles A, Zambidis ET, Gearhart J, Kerr C. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells. Stem Cells and Development. PMID 26154167 DOI: 10.1089/Scd.2015.0100  0.484
2015 Sgambato JA, Park TS, Miller D, Panicker LM, Sidransky E, Lun Y, Awad O, Bentzen SM, Zambidis ET, Feldman RA. Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis. Stem Cells Translational Medicine. 4: 878-86. PMID 26062980 DOI: 10.5966/Sctm.2014-0213  0.38
2015 Klein O, Steppan D, Robey N, Gamper C, Loeb D, Zambidis E, Cooke KR, Chen A, Symons HJ. Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.122  0.416
2014 Huo JS, Baylin SB, Zambidis ET. Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair. Current Opinion in Genetics & Development. 28: 43-9. PMID 25461449 DOI: 10.1016/J.Gde.2014.09.008  0.452
2014 Gorospe G, Zhu R, Millrod MA, Zambidis ET, Tung L, Vidal R. Automated grouping of action potentials of human embryonic stem cell-derived cardiomyocytes. Ieee Transactions On Bio-Medical Engineering. 61: 2389-95. PMID 25148658 DOI: 10.1109/Tbme.2014.2311387  0.371
2014 Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, Burridge PW, Talbot CC, Asnaghi L, Martin LJ, Zambidis ET, Koliatsos VE. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells and Development. 23: 2996-3010. PMID 25027006 DOI: 10.1089/Scd.2013.0511  0.569
2014 Park TS, Bhutto I, Zimmerlin L, Huo JS, Nagaria P, Miller D, Rufaihah AJ, Talbot C, Aguilar J, Grebe R, Merges C, Reijo-Pera R, Feldman RA, Rassool F, Cooke J, ... ... Zambidis ET, et al. Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature. Circulation. 129: 359-72. PMID 24163065 DOI: 10.1161/Circulationaha.113.003000  0.492
2013 Burridge PW, Zambidis ET. Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes. Methods in Molecular Biology (Clifton, N.J.). 997: 149-61. PMID 23546754 DOI: 10.1007/978-1-62703-348-0_12  0.666
2013 Huo JS, Zambidis ET. Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochimica Et Biophysica Acta. 1830: 2385-94. PMID 23104383 DOI: 10.1016/J.Bbagen.2012.10.014  0.399
2013 Park TS, Zimmerlin L, Zambidis ET. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 83: 114-26. PMID 22736485 DOI: 10.1002/cyto.a.22090  0.506
2012 Shah SN, Kerr C, Cope L, Zambidis E, Liu C, Hillion J, Belton A, Huso DL, Resar LM. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. Plos One. 7: e48533. PMID 23166588 DOI: 10.1371/Journal.Pone.0048533  0.56
2012 Panicker LM, Miller D, Park TS, Patel B, Azevedo JL, Awad O, Masood MA, Veenstra TD, Goldin E, Stubblefield BK, Tayebi N, Polumuri SK, Vogel SN, Sidransky E, Zambidis ET, et al. Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease. Proceedings of the National Academy of Sciences of the United States of America. 109: 18054-9. PMID 23071332 DOI: 10.1073/Pnas.1207889109  0.311
2012 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Zambidis ET, Tung L. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility. Progress in Biophysics and Molecular Biology. 110: 166-77. PMID 22971665 DOI: 10.1016/J.Pbiomolbio.2012.07.013  0.467
2012 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Progress in Biophysics and Molecular Biology. 110: 178-95. PMID 22958937 DOI: 10.1016/J.Pbiomolbio.2012.07.012  0.456
2012 Park TS, Huo JS, Peters A, Talbot CC, Verma K, Zimmerlin L, Kaplan IM, Zambidis ET. Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors. Plos One. 7: e42838. PMID 22905176 DOI: 10.1371/Journal.Pone.0042838  0.472
2012 Thompson SA, Burridge PW, Lipke EA, Shamblott M, Zambidis ET, Tung L. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. Journal of Molecular and Cellular Cardiology. 53: 15-23. PMID 22713758 DOI: 10.1016/J.Yjmcc.2012.01.023  0.563
2012 Resar L, Shah SN, Kerr C, Cope L, Zambidis E, Belton A, Huso DL. HMGA1, a Factor Enriched in Hematopoietic Stem Cells, Embryonic Stem Cells, and Hematologic Malignancy, Enhances Cellular Reprogramming to a Pluripotent Stem-Like Cell. Blood. 120: 2323-2323. DOI: 10.1182/Blood.V120.21.2323.2323  0.565
2012 Shah SN, Kerr C, Cope L, Mali P, Zambidis E, Lui C, Hillion J, Belton A, Huso D, Resar L. Abstract 429: The high mobility group A1 oncogene enhances cellular reprogramming to a pluripotent stem-like cell Cancer Research. 72: 429-429. DOI: 10.1158/1538-7445.Am2012-429  0.535
2011 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Plos One. 6: e18293. PMID 21494607 DOI: 10.1371/Journal.Pone.0018293  0.64
2010 Ohm JE, Mali P, Van Neste L, Berman DM, Liang L, Pandiyan K, Briggs KJ, Zhang W, Argani P, Simons B, Yu W, Matsui W, Van Criekinge W, Rassool FV, Zambidis E, et al. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Research. 70: 7662-73. PMID 20841480 DOI: 10.1158/0008-5472.Can-10-1361  0.496
2010 Peters A, Burridge PW, Pryzhkova MV, Levine MA, Park TS, Roxbury C, Yuan X, Péault B, Zambidis ET. Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells. The International Journal of Developmental Biology. 54: 965-90. PMID 20563986 DOI: 10.1387/Ijdb.093043Ap  0.674
2010 Pryzhkova MV, Peters A, Zambidis ET. Erythropoietic differentiation of a human embryonic stem cell line harbouring the sickle cell anaemia mutation. Reproductive Biomedicine Online. 21: 196-205. PMID 20541472 DOI: 10.1016/j.rbmo.2010.04.017  0.492
2009 Park TS, Zambidis ET, Lucitti JL, Logar A, Keller BB, Péault B. Human embryonic stem cell-derived hematoendothelial progenitors engraft chicken embryos. Experimental Hematology. 37: 31-41. PMID 18954935 DOI: 10.1016/J.Exphem.2008.08.007  0.388
2009 Pryzhkova M, Tripathi A, Peters A, Yuan X, Sullivan D, Zambidis E. Efficient long-term expansion of primitive erythroblasts from a human pluripotent stem cell line harbouring the homozygous sickle cell anaemia mutation Reproductive Biomedicine Online. 18. DOI: 10.1016/S1472-6483(10)61211-4  0.495
2008 Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X, Pryzhkova M, Péault B. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood. 112: 3601-14. PMID 18728246 DOI: 10.1182/Blood-2008-03-144766  0.375
2008 Pryzhkova M, Yuan X, Tripathi A, Sullivan D, Zambidis E. Efficient Erythroid Differentiation of a PGD-Derived Human Pluripotent Stem Cell Line Affected with Sickle Cell Hemoglobinopathy Blood. 112: 539-539. DOI: 10.1182/Blood.V112.11.539.539  0.559
2007 Zambidis ET, Sinka L, Tavian M, Jokubaitis V, Park TS, Simmons P, Péault B. Emergence of human angiohematopoietic cells in normal development and from cultured embryonic stem cells. Annals of the New York Academy of Sciences. 1106: 223-32. PMID 17360801 DOI: 10.1196/Annals.1392.010  0.473
2006 Zambidis ET, Oberlin E, Tavian M, Péault B. Blood-forming endothelium in human ontogeny: lessons from in utero development and embryonic stem cell culture. Trends in Cardiovascular Medicine. 16: 95-101. PMID 16546690 DOI: 10.1016/J.Tcm.2006.01.005  0.447
2006 D'Costa J, Friedman AD, Zambidis E, Civin CI. 342. RUNX1 Increases Proliferation of Embryoid Bodies Derived from Human Embryonic Stem Cells Molecular Therapy. 13: S130. DOI: 10.1016/J.Ymthe.2006.08.400  0.449
2005 Zambidis ET, Peault B, Park TS, Bunz F, Civin CI. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood. 106: 860-70. PMID 15831705 DOI: 10.1182/Blood-2004-11-4522  0.41
2000 Agarwal RK, Kang Y, Zambidis E, Scott DW, Chan CC, Caspi RR. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis Journal of Clinical Investigation. 106: 245-252. PMID 10903340 DOI: 10.1172/Jci9168  0.334
Show low-probability matches.